TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
VSTM

Verastem Inc

Healthcare · Biotechnology

7.80$ -4.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement VSTM
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – 100.0% 100.0% 100.0% 100.0% 100.0% – 100.0% 100.0%
– – – – – – – – 2.2% 16.1% 38.1% 10.0% 4.5% – 0.3% 17.1%
– – – – – – – – 97.8% 83.9% 61.9% 100.0% 100.0% – 100.0% 82.9%
– – – – – – – – 163.4% 262.2% 46.7% 1,916.6% 1,947.5% – 813.3% 370.7%
– – – – – – – – 289.2% 579.8% 70.9% 1,174.6% 962.1% – 436.2% 262.5%
– – – – – – – – 452.6% 842.1% 117.6% 3,091.2% 2,909.6% – 1,249.6% 633.2%
– – – – – – – – -354.8% -758.1% -55.8% -2,991.2% -2,809.6% – -1,149.6% -550.3%
– – – – – – – – 21.7% 118.1% 17.8% 485.7% 82.3% – 45.6% 3.7%
– – – – – – – – -271.1% -854.8% -76.3% -3,468.1% -2,843.3% – -1,304.5% -677.6%
– – – – – – – – 105.4% 114.4% 0.2% 482.2% 1.4% – 1.8% –
– – – – – – – – -271.1% -854.8% -76.5% -3,468.1% -2,843.3% – -1,306.4% -677.6%
– – – – – – – – -244.0% -724.2% -57.0% -2,978.9% -2,756.4% – -1,258.6% -671.6%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?